Our findings revealed that CLNM is associated with gender (male), age (≤ 30 years old), tumor lesion size (> 0.855 cm), and multiple tumor lesions in PTC patients. Central Lymph Node Dissection (CLND) is recommended for patients with these risk factors. On the other hand, preoperative ultrasound examination, fine-needle pathological examination, and genetic testing should be used to determine whether Lateral Cervical Lymph Node Dissection (LLND) is needed.
Keyphrases
- lymph node
- risk factors
- end stage renal disease
- rectal cancer
- sentinel lymph node
- ejection fraction
- newly diagnosed
- magnetic resonance imaging
- chronic kidney disease
- ultrasound guided
- lymph node metastasis
- patients undergoing
- prognostic factors
- peritoneal dialysis
- air pollution
- mental health
- single cell
- neoadjuvant chemotherapy
- computed tomography
- patient reported outcomes
- squamous cell carcinoma
- locally advanced